PUBLISHER: TechNavio | PRODUCT CODE: 1525357
PUBLISHER: TechNavio | PRODUCT CODE: 1525357
The cancer diagnostics market is forecasted to grow by USD 17744.5 mn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the cancer diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of cancer, demand for personalized medicines, and need for cost-cutting in drug discovery and development.
Technavio's cancer diagnostics market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 11.73% |
CAGR | 13.64% |
Incremental Value | $17744.5mn |
By End-user
By Type
By Geographical Landscape
This study identifies the increase in r and d and advances in technology as one of the prime reasons driving the cancer diagnostics market growth during the next few years. Also, adoption of various strategies like licensing agreements and commercializing products and vendors focusing on emerging countries with large populations to expand their presence will lead to sizable demand in the market.
The report on the cancer diagnostics market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading CANCER diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Astellas Pharma Inc., Becton Dickinson and Co., bioMerieux SA, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., General Electric Co., GlaxoSmithKline PLC, Hologic Inc., Illumina Inc., Merck KGaA, Myriad Genetics Inc., Novartis AG, Pfizer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.. Also, the CANCER diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: